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Abstract
Chromosomal instability leading to aneuploidy occurs in most sporadic colorectal cancers (CRCs) and is believed to
be an early driving force in disease progression. Despite this observation, the cellular advantages conferred by these
cytogenetic alterations are poorly understood. Here, we provide evidence that serum-free passage of originally diploid,
immortalized human colonic epithelial cells (HCECs) gave rise to the acquisition of trisomy 7 (+7), an aneuploidy de-
tected in more than 40% of colorectal adenomas. These cells remain diploid under long-term growth in 2% serum
conditions. Analysis by GTG banding and fluorescent in situ hybridization detected no rare preexisting +7 cell in the
original population, suggesting a conversion of diploid cells to an aneuploid state. The acquisition of +7 also precedes
loss or truncation of the adenomatosis polyposis coli gene as both diploid and +7 cells express full-length, functional
protein. Coculturing of fluorescent-labeled cells demonstrate that +7 HCECs have a growth advantage over diploid
cells in serum-free conditions.Defects in cellmigration and aberrant regulationof the epidermal growth factor receptor,
located on chromosome 7p, are also detected in +7 HCECs. Interestingly, knockdown of TP53 and expression of
K-RasV12 in +7 HCECs resulted in the emergence of trisomy 20, another nonrandom aneuploidy observed in ∼85%
of CRC. In summary, we describe isogenic colonic epithelial cells that represent cytogenetic changes occurring fre-
quently in sporadic CRC. The emergence and characterization of trisomy 7 and 20 demonstrate that these HCECsmay
serve as unique human cell–based models to examine the effects of chromosomal instability in CRC progression.
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Introduction
Sporadic colorectal cancer (CRC) arises from the sequential accumula-
tion of nonrandom genetic and epigenetic alterations that drive normal
colonic epithelium toward neoplastic transformation [1]. A hallmark
observed in most epithelial cancers is the development of chromosomal
instability (CIN) [2]. CIN is prominent in sporadic CRC patients [3]
and describes the process by which cells accrue increasing amounts of
aneuploidy, an abnormal number of chromosomes [4]. As cells develop
alterations in critical cell cycle control pathways, an increased incidence
of aneuploidy can be detected as cells progressively become more trans-
formed [5]. This suggests that aneuploidy may be a key factor in the
early events of CRC initiation that predisposes cells toward tumori-
genesis [6]. Although CIN can be observed in ∼85% of sporadic
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CRC cases [7], the causes and consequences of CIN and aneuploidy
remain largely unknown [8].
Improved human cellular reagents modeling early CIN events in
CRC pathogenesis are required tomore clearly characterize the biologic
effects of aneuploidy and to identify novel strategies for chemopreven-
tion. We have recently developed a method to isolate and immortalize
human colonic epithelial cells (HCECs) derived from noncancerous
tissues of patients undergoing routine screening or surveillance colonos-
copy [9]. Immortalized HCECs (termed HCEC CT for transduction
with Cdk4 and hTERT ) remain diploid under long-term propagation
in 2% serum growth conditions and do not exhibit any malignant
phenotypes (e.g., anchorage-independent growth, invasion through ex-
tracellular matrices, tumor formation in immunocompromised mice).
However, we have observed one of the earliest known events in CRC
initiation on long-term serum-free cultivation of one HCEC line: the
development of CIN.
The pattern of CIN leading to aneuploidy inCRC seems to be at least
partially nonrandom. Specific chromosomal changes (such as trisomies
or loss of chromosome arms) become apparent during the adenoma
stage, whereas other changes become evident in more advanced lesions
[10]. One of the earliest alterations that occur in up to ∼40% of colonic
adenomas is the development of trisomy for chromosome 7 (+7) [10–
13]. An HCEC line propagated in our laboratory (HCEC 1CT) was
derived from a patient with a previous history of sigmoid adenocar-
cinoma. After immortalization, these noncancerous cells were placed
in serum-free culture for an extended period and the emerged cells
contained +7 as the sole cytogenetic abnormality. We have initiated ex-
periments with these +7 cells (HCEC 1CT+7) to elucidate if and how
this single but common chromosomal alteration may confer a selective
advantage to cells [14]. Recent experiments from yeast studies show
that aneuploidy can be beneficial under a range of stress conditions by
providing a growth advantage [15], although these findings have not
been replicated using human cells.
We report here the isolation and initial characterization of 1CT+7
HCECs. We provide evidence that these aneuploid cells possess a mea-
surable growth advantage under serum-deprived conditions and obtain
other changes (e.g., defective cell migration) that may affect normal
colonic physiology and promote tumorigenesis. In addition, we also
describe the emergence of trisomy 20 (+20) HCEC subpopulations
after introducing defined oncogenic changes into 1CT+7 HCECs. Be-
cause +7 and +20 are common and recurrent chromosomal abnormal-
ities frequently detected throughout various CRC stages [16–18], these
isogenically derived HCEC lines provide a valuable cell-based model
to further dissect the biologic consequences behind aneuploidy-driven
CRC and may serve as useful reagents in the discovery of novel chemo-
preventive strategies.
Materials and Methods
Cell Culture
The culture conditions of HCECs have been reported elsewhere
[9,19]. Briefly, HCECs are maintained under 2% oxygen and 5%
carbon dioxide on Primaria (BD Biosciences, San Jose, CA) plates in
4:1 high-glucose Dulbecco modified Eagle medium/medium 199 with
2% cosmic calf serum (Hyclone, Logan, UT) plus growth supplements:
epidermal growth factor (EGF; 20 ng/ml; Peprotech, Rocky Hill, NJ),
hydrocortisone (1 mg/ml), insulin (10 mg/ml), transferrin (2 mg/ml),
and sodium selenite (5 nM) (all Sigma, St Louis, MO).
Karyotype and Fluorescent In Situ Hybridization
HCECs at 70% confluency were treated with 0.01 μg/ml colcemid
(KaryoMax; Gibco/Invitrogen, Carlsbad, CA) for 2 hours, and meta-
phase chromosomes were harvested under standard protocols. Slides
were dropped using a Thermotron chamber (Thermotron, Inc,Holland,
MI) and stained with G bands by trypsin using Giemsa. The images of
each metaphase were captured with a Zeiss Axioskop 2 microscope
(Photometrics, Tucson, AZ), and Applied Imaging CytoVision Soft-
ware (Applied Imaging Corp., Spring Valley, NY) was used to analyze
these metaphase cells, and each chromosome analysis was performed
on at least 20 metaphases at each PD. DNA probes specific for human
centromeres of chromosomes 7 and 20 (CEP7 and CEP20) were ob-
tained from Abbott Molecular, Inc (Des Plaines, IL) for fluorescent
in situ hybridization (FISH) analysis using a Zeiss Axioskop 2 fluores-
cent microscope with CCD camera (Photometrics). At least 500 inter-
phase cells at each PD were examined.
Coculturing Competition Assays
HCECs were labeled with dsRed by transduction with a pSSI-8018
lentiviral vector followed by blasticidin selection. Two hundred thou-
sand nonlabeled HCEC 1CT cells were mixed with equal numbers
of dsRed-labeled HCEC 1CT+7 cells in a 10-cm2 plate. Cells were
cultured for at least 38 days in serum-free medium with growth sup-
plements and passaged every 8 days. Phase/fluorescence pictures are rep-
resentative images from the center of triplicate culture plates. Control
experiments represent the coculturing of nonlabeled and labeledHCEC
1CT+7 cells.
Western Blot Analysis
Total cell lysates were prepared by harvesting cells in Laemmli SDS
reducing buffer. Protein concentrations were measured using a Pierce
BCA protein assay kit (Thermo Scientific, Rockford, IL), resolved on
an 8% to 10% polyacrylamide gel, and transferred to polyvinylidine
fluoride. Ultracentrifugation was used to fractionate lysates as specified.
Table W1 lists the primary antibodies used. HRP-conjugated goat anti-
mouse or antirabbit ( Jackson ImmunoResearch, West Grove, PA) were
used as secondary antibodies at 1:5000 and detectedwith SuperSignalWest
Pico or Femto Chemiluminescent Substrate Kit (Thermo Scientific).
Bands were quantified using a ChemiDoc XRS+ Imager with Image
Lab software (Bio-Rad, Hercules, CA) and normalized to β-actin.
Response to EGF and Cetuximab
For cell counting experiments, 8.0 × 104 cells were cultured in the
presence of 0, 1, 2.5, or 5 ng/ml EGF in a six-well dish in serum-free
medium with growth supplements with either 50 μg/ml cetuximab
(Erbitux; ImClone Systems, Inc, Branchburg, NJ) or saline. Cell num-
bers were obtained 5 days later. For Western blots with cetuximab,
serum/EGF–starved cells were treated with 0 to 50 μg/ml cetuximab
for 1 hour before stimulation with 5 ng/ml EGF for 15minutes. Lysates
were collected immediately and analyzed as previously described.
Colony Formation Assay
Cells were seeded in triplicate 10-cm2 culture plates at three different
clonal densities (50-400 cells per plates) in either serum or serum-free
medium containing growth supplements. After 10 days, colonies were
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washed with PBS, stained for 30 minutes with 6% glutaraldehyde/
0.5% crystal violet solution, and counted.
Migration Assays
Transwell migration assays were performed using a modified Boyden
chamber. Briefly, 4.0 × 104 cells were serum-starved for 6 hours and
plated into serum-free andGF-freemedium onto 8.0-μmpore transwell
PETmembranes (BD Biosciences, Bedford, MA). Five hundred micro-
liters of medium containing 2% serum and growth supplements was
added to the bottomwell. Nonmigratory cells were scraped off 24 hours
later, and migratory cells were fixed in 100% methanol, washed, and
stained with 4′,6-diamidino-2-phenylindole. Experiments were per-
formed in triplicate transwells and quantified by averaging the number
of DAPI nuclei per 20× field of view counting five fields per chamber
(n = 15). Wound migration assays were performed by plating cells to
confluency in a six-well plate in serum-free medium with growth sup-
plements. After 24 hours, a wound was created by scratching the con-
fluent monolayer with a P200 pipette tip and debris was removed by
PBSwashes. The wound was imaged by phase microscopy at themiddle
of the scratch line at different time points. Cells migrated into the
wound were counted and averaged from triplicates.
Results
Emergence of HCEC 1CT+7 from Diploid Populations
The HCEC 1CT line used in these experiments were derived from
a patient with a previous history of CRC and maintain a normal karyo-
type (46,XY)when continuously propagated in 2%oxygen andmedium
containing 2% serum [9]. As a separate experiment, a subset of HCEC
1CTs were cultured and passaged under serum-free conditions for a pro-
longed period and underwent a phase of slow growth. At approximately
40 population doublings (PDs), 2% serumwas added to the cultureme-
dium (Figure 1A). Cells that emerged from this population contained +7
as the sole cytogenetic change (Figure 1B). No distinct differences were
observed in cell morphology between the two cell types (Figure W1A).
Although we cannot rigorously prove that an extremely rare +7 cell did
not preexist in the population during the time of serum-free culture,
GTG-banding and FISH analysis of the original population at early
PD showed no evidence of a rare subpopulation of cells containing +7
(all 1000 interphase cells were diploid for chromosome 7 by FISHusing
a chromosome 7–specific probe) (Figure 1, C–D). Emerged HCEC
1CT+7 populations were confirmed by analyzing metaphase cells
by GTG banding (50/50 cells analyzed) and FISH (500/500 cells
analyzed) (Figure 1D). Array CGH analyses (NCBI GEO accession
Figure 1. Trisomy 7 HCECs (HCEC 1CT+7) appeared under long-term culture in serum-free conditions. (A) Growth curve of originally diploid
cells propagated in either serumor serum-free conditions. Long-termculture ofHCEC1CT in serummaintains a diploid karyotype. Serum-free
HCEC 1CT underwent a period of slow growth around PD30 in which case 2% serum was added to the culture at PD40. (B) The emerged
population of cells originallymaintained under serum-free conditions displayed a trisomy for chromosome7 by karyotypic analysis as the sole
cytogenetic alteration. (C) FISH analysis on early and late PD cells using a chromosome 7–specific probe. (D) Trisomy 7 cells emerged from
originally diploid HCECs with no early traces of a small aneuploid population.
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numbers: GSE24092 and GSM593069-GSM593070) also revealed
no other large amplifications or deletions other than whole chromo-
some 7 amplifications (Figure W1B).
Acquisition of Trisomy 7 Precedes Loss or Truncation
of Adenomatosis Polyposis Coli
Loss or truncation of the adenomatosis polyposis coli (APC) gene is
believed to be the earliest genetic lesion responsible for the generation
of CIN and initiation toward the adenoma stage [20]. HCEC 1CTand
1CT+7 both express abundant levels of full-length APC, whereas
DLD-1 cancer cells express the truncated form (Figure 2). Furthermore,
we show that Axin2 is not detected in HCECs using the same lysates on
a polyacrylamide gel, suggesting that APC is fully functional in these
cells (Figure 2). Axin2, a negative feedback regulator of the Wnt signal-
ing pathway, is upregulated in the presence of Wnt ligands and nuclear
β-catenin [21]. With functional APC, downstream components of
β-catenin (such as Axin2) are not expressed. Therefore, the generation
of CIN and subsequent acquisition of +7 appears before loss or trun-
cation of APC in the HCEC 1CT line.
Diploid HCECs Lose Growth Advantages in
Serum-Free Conditions
We next tested whether serum affects the clonogenicity of these cells
(Figure 3A). Colony formation assays indicate that, in the presence of
serum, diploid cells have a higher percentage of colony forming cells
compared with 1CT+7. However, in serum-depleted conditions, the
clonogenicity of 1CT HCECs significantly decreases although there
are no effects on 1CT+7 cells, suggesting that diploid cells lose prolifer-
ative advantages when shifting frommore optimal (serum) conditions to
more stressful (serum-free) conditions.
In agreement with previous reports using other cell systems [22,23],
we observed that diploid 1CT HCECs proliferate more rapidly com-
pared to 1CT+7 HCECs in the presence of 2% serum and growth
supplements (0.9 PD/d [26.6 h/doubling] compared with 0.7 PD/d
[34.3 h/doubling], respectively). However, in defined medium only
supplemented with growth factors, both cell types divide at approxi-
mately equal rates (0.3 PD/d [80 h/doubling]). To differentiate the
nearly identical growth rates between 1CTand 1CT+7 HCECs in de-
fined medium, we cocultured equal numbers of nonlabeled diploid
cells with dsRed-labeled 1CT+7 cells for more than a month in serum-
free medium. After 38 days, most cells in culture were dsRed-positive
1CT+7 HCECs (Figure 3B). In control assays, coculturing nonlabeled
1CT+7 cells with dsRed-labeled 1CT+7 cells showed no apparent
differences after several weeks in culture (Figure 3B). In experiments
with 2% serum, diploid cells quickly took over the culture (data not
shown). Reversing the labeled cells also had no effect on these observa-
tions (data not shown).
Aberrant Epidermal Growth Factor Receptor
Regulation in HCEC 1CT+7
Because the epidermal growth factor receptor (EGFR) is located on
chromosome 7, we hypothesized that EGFR misregulation may be a
critical alteration in +7 HCECs [24]. We found a larger-than-expected
increase in EGFR protein levels in 1CT+7 cells compared with diploid
HCECs in both serum and serum/EGF–free conditions after 5 days in
culture (Figure 4A). Next, we measured EGFR levels in both cell types
when serum/EGF–starved during a period of 1, 3, and 5 days. Although
both cell types express similar levels of EGFR after 1 day of passage,
1CT+7 cells exhibits increased EGFR levels during a period of 5 days,
whereas EGFR in diploid HCECs remain at more constant levels
throughout (Figure 4B). Analysis of fractionated lysates byWestern blot
also indicates the localization of EGFR to the cell membrane in both
1CT and 1CT+7 cells (Figure 4C).
Because diverse cell types with various EGFR levels respond differ-
ently to EGFR-targeting therapies, we decided to test whether there are
different responses to an EGFR inhibitor between HCEC 1CT and
1CT+7. Cetuximab, a monoclonal antibody targeting the extracellular
domain of EGFR [25], can effectively inhibit EGFR activation induced
by short-term EGF stimulation in both 1CTand 1CT+7 (FigureW2A).
Interestingly, 1CT+7 cell proliferation induced by various concentra-
tions of EGF in the growth medium is more potently reduced in vitro
in the presence of cetuximab after 5 days in culture compared with
diploid cells (Figure 4D), perhaps indicating an augmented depen-
dency on EGFR signaling in +7 HCECs. In addition, no mutations
were detected in the tyrosine kinase domains of EGFR by exon se-
quencing in both cell types (primers listed in Table W2).
HCEC 1CT+7 Have Defects in Cell Migration
To further characterize 1CT and 1CT+7 HCECs, we next investi-
gated if there are any differences in cell motility. Cell migration is an
important factor in the rapid turnover of colonic crypts [26], and defects
in cell motility could thus provide an initial survival advantage in the
early stages of CRC (e.g., retention of epithelial cells within crypts,
increased time frame to accumulate mutations). Using a transwell mi-
gration assay, 1CT+7 HCECs exhibited defects in cell migration
through a porous membrane toward serum-containing medium (Fig-
ure 5, A and B). This loss in migration ability is also recapitulated in a
two-dimensional wound migration assay (Figure 5, C and D). In con-
trast to diploid cells, 1CT+7HCECs have a decreased ability to migrate
into the wound area. These results suggest a disruption in the highly
regulated process of cell migration [27]. Analysis of matrix metallo-
proteinases (MMPs) by gelatin zymography also reveals a significant re-
pression of pro–MMP-2 levels in HCEC 1CT+7 compared with
HCEC 1CT and 2CT (an immortalized normal cell line from a non-
CRC patient) (Figure W2B).
Figure 2. Expression of full-length, functional APC in both diploid
and trisomy 7 HCECs. The CRC cell line DLD-1 is used as a positive
control for truncated APC. The same lysates were also probed for
Axin2, a protein upregulated in the presence ofWnt ligands and sub-
sequent nuclear β-catenin.
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Emergence of Trisomy 20 in HCEC 1CT+7 Expressing
K-RasV12 and shTP53
Next, we attempted to experimentally transform these HCECs
in vitro by recapitulating commonly observed genetic events in CRC
progression. We started by introducing the K-RasV12 oncogene and
stably depleting TP53 levels using short hairpin RNA (shRNA) [28]
in both 1CT and 1CT+7 HCECs (termed HCEC 1CTRP and
1CTRP+7, respectively) (Figure 6A). Interestingly, metaphase spreads
revealed that only 1CTRP+7HCECs (and not diploid 1CTRP cells) dis-
played a trisomy for chromosome 20 (+20) in 20% of the population
(7/35 cells analyzed by GTG banding) (Figure 6B). These results were
also confirmed by FISH (Figure W2C). After isolating a clonal popula-
tion of +20 cells, we determined that +20had no obvious effects on clono-
genicity in anchorage-dependent colony formation assays (Figure 6C) or
anchorage-independent assays in soft agar (Figure 6D). Alterations to
K-Ras and TP53, however, increased serum-free anchorage-dependent
clonogenicity from ∼15% in 1CT and 1CT+7 cells (Figure 3A) to
∼50% to 55% in 1CTRP+7 and 1CTRP+7, +20 cells (Figure 6C). Un-
like diploid 1CT cells, it seems that the absence or presence of serum
has no effect on the clonogenicity of aneuploid HCECs. These 1CTRP
+7, +20 HCECs could further serve as models to study CIN-mediated
CRC progression, most likely representing later-staged adenomas.
However, these cells still do not fully represent the transformed state
because they lack the ability to form tumors in immunocompromised
mice (data not shown).
Discussion
We have isolated isogenic derivatives of HCECs from the same biopsy
tissue that are either diploid when maintained in 2% serum or acquire
+7 trisomy under serum-free conditions. Analysis of a large sampling of
cells byGTG banding and FISH detected no preexisting trisomy cells in
the original population, arguing for conversion rather than selection.
While we cannot formally prove that rare +7 cells did not preexist in
the original diploid population, its frequency is less than 1 of 1000 cells.
Our data support the hypothesis that, in the initial stages of culture, a
cell from an originally diploid population underwent CIN and subse-
quent de novo conversion to a +7 cell. This was followed by a selective
growth advantage for the rare +7 cell type in serum-deprived culture
conditions to eventually outcompete diploid cells within the population.
Figure 3. Diploid HCECs lose growth advantages when cultured in serum-free medium. (A) HCECs were plated at clonal density in
serum or serum-free medium for 10 days. The absence of serum significantly reduces the clonogenicity of 1CT but has no effect on
1CT+7 cells. (B) DsRed-labeled 1CT+7 cells were mixed with an equal number of nonlabeled 1CT cells and passaged in serum-free
growth medium. Late passage represents approximately 38 days in culture, splitting the cells once every 8 days. Control experiments
with nonlabeled 1CT+7 show no differences in the ratio of dsRed-positive to negative cells. Columns represent mean ± SEM. P values
obtained by two-tailed, unpaired Student’s t test.
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This intrinsic defect leading to CIN seems to be specific to the HCEC
1CT line because cells from another patient (HCEC 2CT) do not pos-
sess any chromosomal alterations under the same experimental con-
ditions. Figure 7 provides a schematic placing our observations in the
context of the current CRC progression paradigm.
Mutation or epigenetic misregulation of the APC gene is one of the
earliest known alterations in CRC progression and has been shown to
be a significant factor in the generation of CIN [20]. Although APC has
many known functions, it is currently unknown exactly how loss of APC
leads to the accrual of aneuploidy. Truncation events are the main cause
in a majority of APC-inactivated CRC cases [29] followed by promoter
hypermethylation [30]. We have shown that both 1CT and 1CT+7
HCECs express full-length APC protein. In addition, DNA sequencing
of the APC mutation cluster region reveals no preexisting mutations
(primers listed in Table W2). Pyrosequencing was also used to confirm
hypomethylated promoters in both the diploid and trisomy lines (0%-
2% methylation in 1CT, 1CT+7, and 2CT cells) (data not shown).
Contrary to other reports [31–34], our results suggest that APC loss
is not required for the onset of CIN in theHCEC1CT line. In addition,
we did not observe any differences in messenger RNA transcript levels
for Sgo1 and Bub1 by quantitative polymerase chain reaction (data not
shown), two frequently downregulated genes in colon cancer associated
with increased levels of CIN [35,36].
Aneuploidy is generally disadvantageous to cells in nonstressful envi-
ronments. For example, under normal growth conditions, aneuploid
mouse embryonic fibroblasts have an overall decreased cellular fitness
compared to diploid fibroblasts [22]. This suggests that cells may de-
velop other changes to overcome the initial chromosomal aberration
to prevent elimination from the population [37]. This mechanism of
compensation for additional chromosomes may confer unknown fitness
advantages under specific conditions that allow aneuploid cells to out-
compete diploid cells [15]. We hypothesize that under stressful or non-
optimal growth conditions, 1CT+7 HCECs gained a growth advantage
over their diploid counterparts and this gain may act as a mechanism
for cancer initiation [38]. When shifted to serum-free conditions, we
show that diploid HCECs lose growth advantages, whereas aneuploid
cells gain a slight growth advantage. Thus, the emergence of an extra
chromosome could confer a selective advantage to 1CT+7 cells to out-
compete normal cells and could provide one explanation for early CRC
pathogenesis events in terms of cell competition within colonic crypts. It
Figure 4. HCEC 1CT+7 exhibits aberrant EGFR regulation and cell growth is more potently inhibited by cetuximab. (A) HCEC 1CT+7 ex-
presses higher levels of EGFR in serum and serum-free conditions compared with 1CT as shown by Western blot analyses. (B) Cells were
cultured in serum/EGF–free medium for 1, 3, and 5 days, and lysates were probed for EGFR. 1CT+7 cells show increased EGFR levels in the
absence of serum/EGF over time. Bands were quantified by densitometric scanning and normalized to loading control. (C) Expression of
EGFR is localized to the cell membrane as shown by Western blot analyses on fractionated lysates. Lamin A/C and GAPDH are used as
nonmembrane controls. (D) Cetuximab, an EGFR inhibitor, canmore significantly reduce 1CT+7 cell proliferation induced by EGF compared
with diploid cells. Cells were cultured for 5 days in various concentrations of EGF in the presence of 50 μg/ml cetuximab or saline (n = 3).
Columns represent mean ± SEM. *P < .05, by two-tailed, unpaired Student’s t test.
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is currently unknown whether the aberrant EGFR regulation exhibited
by 1CT+7 HCECs contributes to the conversion or selection pressures
for +7 cells.
Another difference between diploid and trisomy 7 HCECs is a defect
in cell migration in 1CT+7 cells. Proper cell migration is a coordinated
and dynamic process in the physiological turnover of the colonic epi-
thelium [39]. Stem cells at the bottom of the colon crypts give rise
to progenitor cells that differentiate as they migrate toward the lumen
of the colon. As differentiated cells reach the apex of the crypt, they
undergo apoptosis and are shed into the lumen to make way for newer
cells emerging from the base [40]. Thus, the strict regulation in the
number of cells gained at the bottom of crypts roughly equals the
number of cells lost at the apex [41]. Even partial loss of cell migration
within the epithelium could therefore be disruptive to normal colon
crypt physiology [42]. A decrease can be seen in the motility of 1CT
+7 HCECs compared with their diploid counterparts (Figure 4). These
results suggest that, in vivo, +7 HCECs may be slightly impaired in
crypt migration and could thus lead to interference with normal colonic
turnover [27]. This may predispose cells to the accumulation of tumor-
igenic alterations owing to prolonged retention of cells within the crypt.
This defect in 1CT+7 cell migration also correlates with a decrease in
pro–MMP-2 levels (Figure W1C). MMP-2 is expressed in nontumori-
genic mouse colonic epithelial cells [43] and is associated with normal
cell migration and physiological wound healing processes [44]. Al-
though aberrant MMP-2 expression has been implicated in disease
progression and metastatic potential of cancer cells [45], MMP-2 is re-
quired and sufficient to initiate the migration of normal epithelial cells
[46]. Our results suggest a possible association between decreased
MMP-2 levels and reduced +7 epithelial cell migration that may exist
within colonic crypts. In addition, cell models of Down syndrome
(human trisomy 21, mouse trisomy 16) also display perturbed migra-
tory abilities [47,48], although the mechanistic link between aneu-
ploidy and cell migration remains unclear.
Introduction of oncogenic K-RasV12 and stable knockdown of
TP53 in 1CT+7 HCECs (1CTRP+7) led to the emergence of another
nonrandom chromosomal alteration, trisomy 20 (+20), appearing in
20% of the population (1CTRP+7, +20). A clonal isolate was selected
and expanded to generate a pure population of 1CTRP+7, +20HCECs.
Neither expression of K-RasV12 nor TP53 knockdown alone was suffi-
cient to induce any chromosomal abnormalities. These events also could
not be recapitulated in normal diploid 1CTor 2CTHCECs, suggesting
an intrinsic defect within +7 HCECs upon experimental manipulation
of both K-Ras and TP53. These results also provide additional evidence
for the conversion (rather than selection) of preexisting aneuploidy cells
in the initial population because there was no evidence of +20 chromo-
somes unless oncogenic changes were introduced into 1CT+7 cells.
Although the EGFR pathway may contribute to the selective advantage
of 1CT+7 HCECs over diploid cells, the mechanism by which +7, +20
begins to selectively outcompete +7 in HCEC 1CTRP remains un-
known. Interestingly, +7 and +20 events are both frequently detected
throughoutCRCpathogenesis [49], and these cytogenetic changes seem
to be nonrandom. Because it is highly unlikely that such CRC-specific
Figure 5. HCEC 1CT+7 displays defects in cell migration. (A) In a transwell migration assay, cells were seeded in serum-free medium and
allowed to migrate through an 8-μm pore membrane toward either 2% or 0% serummedium. Migrated cells were stained with DAPI. A549
lung cells are used as a positive control for cell migration. (B) Quantification of (A) by averaging the number of cells per 20× magnification
(n=15). (C) HCEC1CT+7are slower tomigrate into a gap createdby anexperimentalwound to the cellmonolayer. (D)Quantification of (C) by
averaging the number of cells that migrated into the gap compared with 0 hours (n= 3). All columns represent mean± SEM. **P< .005, by
two-tailed, unpaired Student’s t test.
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chromosomal changes could be occurring by chance, we believe these
1CTRP+7, +20 HCECs represent a further progressed cell type that
may be recapitulating a hierarchy of frequently observed events through-
out different stages of CRC. These cells with experimentally introduced
oncogenic changes and spontaneous chromosomal abnormalities
appearing within the same population of initially diploid cells could also
contribute to the cellular heterogeneity generally seen among tumor
samples [50].
Figure 6. Introduction of a constitutively active K-RasV12 oncogene and shRNA-mediated depletion of TP53 induces the emergence of tri-
somy 20. (A) Knockdown of TP53 and expression of K-RasV12 in HCEC 1CT+7. (B) Karyotypic analysis reveals +20 in 7 of 35 cells analyzed
by GTG banding. No +20 cells were detected in diploid HCECs under the same conditions. Neither knockdown of TP53 nor expression of
K-RasV12 alone was sufficient to induce +20 in HCEC 1CT+7. The addition of an extra chromosome 20 has no effect on (C) anchorage-
dependent (adherent culture) and (D) -independent (soft agar) clonogenicity. HCT-116 colon cancer cells were used as a positive control
for anchorage independent growth. All columns represent mean ± SEM.
Figure 7. Updated schematic to the current CRC progression paradigm. In the HCEC 1CT model, the appearance of trisomy 7 coinciding
with aberrant EGFR regulation and defects in cell migration precedes the loss or truncation of APC. Trisomy 20 also appears after alterations
to K-Ras or TP53. Because these cells still do not form tumors in mice, there must be other alterations that drive the progression toward the
carcinoma phenotype. The identification of these driver alterations will be the subject of future studies.
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In summary, we describe the isolation and initial characterization
of +7 and +20 HCEC 1CT lines derived from an originally diploid
population. Although the underlying mechanism of CIN in the
HCEC 1CT population has yet to be identified, these isogenic cells will
be useful in studying CIN-mediated CRC initiation and progression in
a genetically tractable human cell–based model. Furthermore, these
cells could serve as reagents for the discovery of novel drug targets that
can exploit specific vulnerabilities in aneuploid HCECs to inhibit their
growth or induce apoptosis for therapeutic purposes.
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Supplementary Materials and Methods
Array Comparative Genomics Hybridization
Total DNAwas isolated using DNeasy Blood & Tissue Kit (Qiagen,
Valencia, CA), and samples were hybridized with Affymetrix (Santa
Clara, CA) Genome-Wide Human SNP 5.0 according to the manu-
facturer’s protocol at the UT Southwestern Genomics and Microarray
Core Facility. Washing and staining were performed on an Affymetrix
Fluidics Station 450, and the array was processed with Affymetrix
GeneChip Operating Software (GCOS) and GeneChip Genotyping
Analysis Software (GTYPE). Data were analyzed using Nexus CGH
(BioDiscovery), and DNA-Chip Analyzer (dChip) was used for back-
ground subtraction and normalization.
Gelatin Zymography
Cells were seeded in six-well plates at 4 × 104 in 2 ml of serum-free
medium. After 40 hours, 32 μl of conditioned medium was collected
and resolved on an 8% polyacrylamide gel containing 0.1% gelatin.
The gel was incubated in 2.5% Triton X-100 for 30 minutes two times
at room temperature with gentle agitation. The gel was then washed
with water and incubated for 18 hours at 37°C in a solution contain-
ing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM CaCl2, and
0.02% NaN3. The gel was then stained with Coomassie R-250 for
30 m followed by destaining and drying onto a blotting paper.
TP53 Knockdown and Expression of K-RASV12
TP53 shRNA expressing HCEC 1CT+7 cells were described else-
where [1]. Retroviral pBABE-hyg-K-rasV12 was used to drive oncogenic
K-Ras expression. Briefly, 2 μg of retroviral vector was transfected to
Phoenix A cells with Effectene (Qiagen). Forty-eight hours after trans-
fection, viral supernatants were collected, cleared through a 0.45-μm
filter, and used to infect HCEC 1CT+7 +shTP53 cells with 4 μg/ml
polybrene (Sigma). Infected cells were selected in 250 μg/ml hygro-
mycin. Reverse transcription–polymerase chain reaction followed by a
diagnostic restriction digestion was used to confirm expression of onco-
genic KRAS as described [2].
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Table W1. List of Primary Antibodies Used for Western Blot Analysis.
Antibody Catalog ID Manufacturer Information
APC OP44 Merck KGaA, Darmstadt, Germany
Axin2 76G6 NEB, Ontario, Canada
β-Actin A1978 Sigma, St Louis, MO
EGFR sc-03 Santa Cruz, CA
GAPDH 14C10 Cell Signaling, Danvers, MA
Lamin A/C V3001 Biomeda Corporation, Foster City, CA
p53 V1003 Biomeda Corporation, Foster City, CA
Phospho-EGFR (Y1173) sc-101668 Santa Cruz, CA
Phospho-ERK (T202/Y204) 9101 NEB, Ontario, Canada
Figure W1. (A) Phase-contrast images of cell morphology for both cell types. (B) Array Comparative Genomics Hybridization analysis
reveals no other large gains or losses of chromosomal segments other than amplification of chromosome 7 in HCEC 1CT+7.
Figure W2. (A) Cetuximab can effectively inhibit EGFR phosphorylation in both 1CT and 1CT+7 cells. Cells were treated with varying con-
centrations of cetuximab for 1 hour before stimulation with 5 ng/ml EGF for 15 minutes. (B) Gelatin zymography detects lower pro–MMP-2
levels secreted by HCEC 1CT+7 than in HCEC 1CT or 2CT. (C) FISH analysis using chromosome 20–specific probes shows 20% (7/35 cells
by GTG banding) trisomy 20 emergence from HCEC 1CTRP+7 populations.
Table W2. List of Polymerase Chain Reaction Primers Used for DNA Sequencing.
Sequenced Region Direction Primer Sequence (5′–3′)
APC–Cluster 1 Reverse GCTGGATTTGGTTCTAGGG
Forward TCCTTCATCACAGAAACAGT
APC–Cluster 2 Reverse GATGACTTTGTTGGCATGGCA
Forward GGTCAGCTGAAGATCCTGTG
EGFR–TK Domain Reverse GCCCTGCTGTGGGATGAGGTACTC
Forward GGAGAAGCTCCCAACCAAGCTCTCTTG
KRAS-Ex1 Reverse GAATGGTCCTGCACCAGTAA
Forward GTGTGACATGTTCTAATATAGTCACA
p53-Ex5 Reverse CCAGCCCTGTCGTCTCTCCA
Forward GCTGCCGTGTTCCAGTTGC
p53-Ex6 Reverse GCCACTGACAACCACCCTTA
Forward GGCCTCTGATTCCTCACTCTGA
p53-Ex7 Reverse AGTGTGCAGGGTGGCAAGTG
Forward TGCCACAGGTCTCCCCAAGG
p53-Ex8 Reverse ATAACTGCACCCTTGGTCTC
Forward CCTTACTGCCTCTTGCTTCT
Regions sequenced here were all normal in the HCEC 1CT line.
